Comparison with existing literature
cancer, colorectal cancer, breast cancer
CANCER, COLORECTAL CANCER, SIDE EFFECT, BREAST CANCER
The study found GPs’ levels of willingness to prescribe aspirin for colorectal cancer prevention to a patient with LS was comparable with a previous cross-sectional UK survey.Barriers were also observed to prescribing aspirin that were consistent with previous research conducted in breast cancer prevention.In the current study, several GPs unwilling to prescribe reported a preference for the clinical geneticist initiating the prescription. Similarly, in breast cancer research, GPs have been observed to be more willing to prescribe preventive medicine to a hypothetical patient at higher risk of cancer if a clinical geneticist makes the first prescription.There are several potential barriers that may prevent aspirin from being initiated in specialist care. Previous UK and Australian research into breast cancer preventive therapy has observed a resistance among hospital-based clinicians to prescribe preventive medicines, given unfamiliarity with prescribing and side effect management,An Australian study also found that specialist clinicians typically viewed GPs as the main prescribers of aspirin for cancer prevention, while perceiving their own roles as more advisory.